Drug Type Small molecule drug |
Synonyms Tazarotene and Betamethasone Dipropionate Cream, 他扎罗汀/倍他米松二丙酸酯 |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists), RARα agonists(Retinoic acid receptor alpha agonists), RARβ2 agonists(Retinoic acid receptor beta agonists) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (27 Mar 2015), |
Regulation- |
Molecular FormulaC28H37FO7 |
InChIKeyCIWBQSYVNNPZIQ-XYWKZLDCSA-N |
CAS Registry5593-20-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Psoriasis | CN | 27 Mar 2015 |